baber/WOPTO huggingface dataset:
Patent AU-759304-B2 (AU)
Title: Method and apparatus
Inventor: LEWIS CLIVE MARTIN
IPC: G08B17/10
Filed: 2000-05-08
Granted: 2003-04-10
Abstract: A method and apparatus for detecting the location of an event from amongst a plurality (A to P) of locations. Lines of communication (R 1 to R 4 , C 1 to C 4 ), commonly pipes of a smoke detection system, cover the locations in such a fashion that the location of an event can be determined uniquely but the number of pipes is minimized.
Patent AU-660562-B2 (AU)
Title: Fluorinated 17beta -substituted 4-aza-5alpha-androstan-3-one derivatives
Inventor: PANZERI ACHILLE
IPC: A61P17/14
Filed: 1993-07-29
Granted: 1995-06-29
Abstract: Compounds of formula (I)    <IMAGE>  (I)  wherein: the symbol  represents a single or a double bond; B is a bond or a straight or branched C1-C6 alkylene chain; R is hydrogen or C1-C4 alkyl; R1 is hydrogen, C1-C6 alkyl or benzyl; R2 is a) hydrogen, fluorine, C1-C6 alkyl, C5-C7 cycloalkyl or C6-C9 cycloalkylalkyl; or b) aryl or C7-C10 arylalkyl; R3 is a) hydrogen, fluorine or C1-C4 alkyl; or b) aryl or C7-C10 arylalkyl; R4 is hydrogen, fluorine, or is absent when Y is a double bond; R5 is hydrogen, fluorine or C1-C6 alkyl; and when Y is a single bond, A is hydrogen, fluorine or   <IMAGE>    wherein each of R6, R7 and R8 independently is hydrogen, fluorine or C1-C6 alkyl; and when Y is a double bond, A is a   <IMAGE>    wherein each of R6 and R7 is independently hydrogen, fluorine or C1-C6 alkyl; with the proviso that at least one of the groups R, R1, R2, R3, R4, R5 or A contains at least one fluorine atom.
Patent AU-624466-B2 (AU)
Title: New thrombolytic compositions
Inventor: POHL GUNNAR
IPC: A61K38/54
Filed: 1990-01-08
Granted: 1992-06-11
Abstract: A thrombolytically active composition comprising in combination a modified tissue-type plasminogen activator (t-PA) as a major component and a normal human t-PA, streptokinase or human urokinase as a minor component in a pharmaceutically acceptable excipient;  a method of treating a thrombotic disorder; and a medicinal kit or package for use in treating thrombotic disorders.
Patent AU-728360-B2 (AU)
Title: Thienylcyclohexanone derivatives as ligands of the gabaa alpha5 receptor subtype
Inventor: BROUGHTON HOWARD BARFF
IPC: A61K31/381
Filed: 1997-10-28
Granted: 2001-01-11
Abstract: A pharamceutical composition comprises a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein A is C1-6alkyl, C2-6alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, arylC1-6alkyl, aryl, S(O)pR1.
Patent AU-630410-B2 (AU)
Title: The use of doubly or triply charged cations in immunochemical assays
Inventor: GIESENDORF BERNHARD
IPC: G01N33/543
Filed: 1990-01-17
Granted: 1992-10-29
Abstract: The use of water-soluble salts of divalent or trivalent cations in immunochemical methods for detecting and determining an analyte in a sample is described. It is shown that these salts increase the specificity of such determinations, in particular the background signal in solid-phase immunochemical methods in which the detection of the analyte takes place on a solid phase is reduced by addition of one of the said salts.
Patent AU-624681-B2 (AU)
Title: Inorganic hydrogel flatting agents
Inventor: WELSH WILLIAM ALAN
IPC: C09D7/00
Filed: 1990-02-15
Granted: 1992-06-18
Abstract: An improved flatting agent comprising an inorganic hydrogel having a pore volume of at least 1.0 ml/g, an average particle size in the range 1 to 10 microns, and a particle size distribution such that when the flatting agent is dispersed in a coating, the fineness of grind is at least 4.75 on the Hegman scale. The inorganic hydrogel flatting agents of this invention are prepared by milling an inorganic hydrogel under controlled temperature conditions wherein a volatiles content of at least 40 weight percent is maintained, to produce inorganic hydrogel particles characterized by a pore volume of at least 1.0 ml/g, an average particle size in the range of 1 to 10 microns, and a particle size distribution such that when the flatting agent is dispersed in a coating, the fineness of grind is at least 4.75 on the Hegman scale. Also provided in accordance with this invention are improved coating compositions comprising a full gloss coating containing the above described flatting agents dispersed in the full gloss coating in from 3 to 15 weight percent loading on a solids basis.
Patent AU-772995-B2 (AU)
Title: Methods of synthesizing polynucleotides by ligation of multiple oligomers
Inventor: AKHAVAN-TAFTI HASHEM
IPC: C12Q1/68
Filed: 1999-07-22
Granted: 2004-05-13
Abstract: Methods of synthesizing polynucleotides are disclosed involving the simultaneous ligation of a set of oligomer 5'-phosphates onto a template-bound primer. The set of these oligomers can be preselected to contain oligomers which are complementary to the template strand or the oligomers can be supplied as a library and allowed to self select. The synthesis by ligation can proceed unidirectionally or bidirectionally from the primer and can be used to synthesize both strands simultaneously by the use of two primers. The ligation is preferably performed with a ligase enzyme. The methods of synthesis are useful in a variety of applications, including cloning, amplification, labeling, diagnostic assays, mutation analysis and screening, gene expression monitoring and sequence analysis.
Patent AU-669236-B2 (AU)
Title: Radiation responsive laparoscopic instrument
Inventor: THURSTON MARLIN O
IPC: G01T1/161
Filed: 1993-12-16
Granted: 1996-05-30
Abstract: A laparoscopic instrument is provided having a hand-grippable base (12) to which an elongate accessing tube (14) is connected which extends to a tip (16). Extending inwardly from the tip (16) is a detection support region (18) within which is formed a radiation transmissive window (22). Immediately spaced from and behind the window (22) there is positioned a detecting crystal (60) such as cadmium telluride which is retained in a crystal mount structure (26) having an architecture designed for minimizing noise generation occasioned from microphonic (piezoelectric) phenomena and the like. <IMAGE>   <IMAGE>
Patent AU-626671-B2 (AU)
Title: Method and apparatus for continuously drying boards coated on both sides
Inventor: HULTZSCH GEUNTER
IPC: F26B15/12
Filed: 1990-05-04
Granted: 1992-08-06
Abstract: Panels 2 having a coating on both sides are guided through a drying device 1 with the aid of transport rollers 4 which are hollow on the inside, designed as cooling rollers and carry a gaseous or liquid coolant flow. In drying zones 8, 9 of the drying device 1, there are heat sources 7, for example IR dark radiators. The transport rollers are arranged parallel to one another and horizontally. Adjacent to the rear - in the direction of transport A of the panels 2 - drying zone 9 is a short cooling zone 5 consisting of transport rollers 4.
Patent AU-576068-B2 (AU)
Title: Skylight connection
Inventor: ALKJAER PETER
IPC: E04D13/02
Filed: 1986-03-21
Granted: 1988-08-11
Abstract: 57 A skirt (7) of finely corrugated sheet of lead is at its top edge assembled in a folded joint with the lower edge of a covering rail (4) mounted on the lower frame portion (3) of a skylight. A plastic and preferably adhesive material strip (8) is incorporated in the joint and is by the pressing together of the joint made to completely fill the corrugations of the skirt edge portion incorporated in the joint to eliminate flat- pressing of the corrugations.
Patent AU-727020-B2 (AU)
Title: Position-adjustable spinal osteosynthesis system
Inventor: COUEDIC REGIS LE
IPC: A61B17/70
Filed: 1997-12-23
Granted: 2000-11-30
Abstract: PCT No. PCT/FR97/02398 Sec. 371 Date Jun. 28, 1999 Sec. 102(e) Date Jun. 28, 1999 PCT Filed Dec. 23, 1997 PCT Pub. No. WO98/29046 PCT Pub. Date Jul. 9, 1998According to an embodiment of the invention, an apparatus is provided that includes positioning equipment for an osteosynthesis system for a spinal column. The positioning equipment includes two elongate anchoring members each designed to be anchored in a vertebra of the column, and an elongate anchoring linking element designed to connect the anchoring members together. The system is designed to have an unlocked configuration in which each anchoring member can turn with respect to the anchoring linking element about a first axis perpendicular to a longitudinal direction of the anchoring member and perpendicular to a longitudinal direction of the anchoring linking element. The system is also designed to have a locked configuration in which each anchoring member is rigidly fixed to the anchoring linking element. The equipment also includes to arms designed to be fixed removably to the two respective anchoring members and an elongate arm linking element designed to connect part of each arm together. The arm linking element is designed to connect the arm parts, defining an extremum for the mutual separation of the arm parts. The arm linking element includes at least one rack which has teeth designed to mesh with one of the arm parts. The rack or racks being fixed, with the ability to rotate, to the other arm part.
Patent AU-583618-B2 (AU)
Title: Electrical terminator device
Inventor: PAPA RALPH A
IPC: H01R13/28
Filed: 1986-04-29
Granted: 1989-05-04
Abstract: A compact electrical terminator device (10) is provided. The device has a circuit board (11) mounted parallel to the mating face of the device between two housings (12, 13). The resistive or other impedance elements (35) are mounted on the side of the circuit board (11) away from the mating face and are covered by a ventilated housing (13). The terminals (34) of the device project directly from the circuit board (11) in the other direction, passing through terminal channels (14) in the other housing (12).
Patent AU-629496-B2 (AU)
Title: Collapsible container apparatus for use in the storage and transportation of fluid material
Inventor: FARRELL PETER JEFFREY
IPC: B65D90/00
Filed: 1990-06-27
Granted: 1992-10-01
Abstract: Collapsible container apparatus (2) for the storage and transportation of fluid material, which collapsible container apparatus (2) comprises a collapsible outer bag (4), a rigid top portion (15) which is attached to sides (12) of the outer bag (4), a rigid base (16), horizontally extending constraint members (20) and elongate support members (22), the outer bag (4) having discharge means (72), and the collapsible container apparatus (2) further including auxiliary discharge means (108) for raising a part of the outer bag (4) opposite the discharge means (72) in order to cause the discharge means (70) to be at the lowest part of the outer bag (4) for complete dis charging of the fluid material.
Patent AU-638473-B2 (AU)
Title: Promoters of colony stimulating factor activity
IPC: C07K14/54
Filed: 1990-07-10
Granted: 1993-07-01
Abstract: The present invention relates to the identification of promoters of myelopoietic blood cell production. In particular, an agent has been discovered that enhances myelopoietic colony stimulating factor activity. The agent comprises cytokines that are also capable of binding to heparin, and inducing localized inflammation characterized by polymorphonuclear cell infiltration when administered subcutaneously. Particular agents comprise the inflammatory cytokines MIP-1 and MIP-2. Diagnostic and therapeutic utilities are proposed, and pharmaceutical compositions are likewise set forth.
Patent AU-697755-B2 (AU)
Title: Method of identifying persons susceptible to group a beta-hemolytic strep tococci-mediated neuropsychiatric disorders
Inventor: SWEDO SUSAN E
IPC: G01N33/53
Filed: 1996-06-06
Granted: 1998-10-15
Abstract: A method of identifying individuals who have, or who are at risk of developing, autoimmune neuropsychiatric disorders is disclosed. The invented method relies on detection of the B lymphocyte antigen, D8/17. The invented method can conveniently be carried out as a simple blood test.
Patent AU-712968-B2 (AU)
Title: Radiometal-binding analogues of leutenizing hormone releasing hormone
Inventor: MCBRIDE WILLIAM J
IPC: C07K14/575
Filed: 1996-06-07
Granted: 1999-11-18
Abstract: Peptide, derivatives of leutenizing hormone releasing hormone that are capable of binding radionuclides are provided. The peptide derivatives are readily labeled with isotopes of rhenium or technetium, while retaining their ability to tightly bind LHRH receptors. Methods for preparing the labeled peptides and their use in methods of radiodiagnosis and radiotherapy are described.
Patent AU-676543-B2 (AU)
Title: Condensed-phase microparticle composition and method
Inventor: FERNANDEZ JULIO M
IPC: A61K9/50
Filed: 1994-02-10
Granted: 1997-03-13
Abstract: An encapsulated microparticle composition and its method of use in drug delivery and diagnostic applications are disclosed. Also disclosed are methods of storing and administering drug compounds at high concentration in condensed-phase microparticles.
Patent AU-636396-B2 (AU)
Title: Quantum well structures
IPC: G02F1/015
Filed: 1990-09-04
Granted: 1993-04-29
Abstract: By forming quantum well (QW) structures with two different heterojunctions having different band offsets it is possible to form QWs having built-in dipoles. The presence of a built-in dipole in a narrow enough well results in QWs having absorption edges which, unlike those of conventional QWs, can be shifted to the blue by application of an electric field of appropriate polarity.
Patent AU-762659-B2 (AU)
Title: Process for the specific detection of glycosylated proteins
Inventor: ROMISCH JURGEN
IPC: G01N33/68
Filed: 1999-12-07
Granted: 2003-07-03
Abstract: A method (I) for the specific detection of glycosylated proteins, is new and comprises incubation of the samples to be investigated with a solid phase coated with a substrate, onto which the protein-bound glycosylated groups bind, washing and detection using monoclonal antibodies. A method (I) for the specific detection of glycosylated proteins, is new and comprises: (a) incubating the sample to be investigated with a solid phase coated with a substrate, to which the protein-bound glycosylated groups bind; (b) removing any unbound sample by washing; (c) exposing the immobilized, glycosylated protein to a marked F(ab) fragment or a F(ab)'2 fragment of a protein-specific monoclonal antibody; and (d) removing any unbound fragments and analyzing the remaining bound parts. An Independent claim is also included for an assay (II) carrying out using (I).
Patent AU-726239-B2 (AU)
Title: 2-phenoxyaniline derivatives
Inventor: OTA TOMOMI
IPC: C07C233/43
Filed: 1998-03-26
Granted: 2000-11-02
Abstract: A 2-phenoxyaniline derivative represented by the formula: <CHEM> wherein R<1> is a hydrogen atom, an amino group or an NHCOR<3> group, R<2> is a halogen atom, an amino group, a cyano group, a C1-6 alkyl group, a C1-3 perfluoroalkyl group, an NHCOR<3> group, a CH2OR<4> group, an OCH2R<5> group or a COR<6> group, R<3> is a C1-6 alkyl group, R<4> is a hydrogen atom or a C1-6 alkyl group, R<5> is a hydrogen atom, a C1-6 alkyl group, a C1-5 aminoalkyl group, a C2-7 alkoxycarbonyl group or a carbamoyl group, and R<6> is a C1-6 alkyl group or a C3-8 cycloalkyl group which is unsubstituted or substituted by a halogen atom, an amino group, a cyano group or a straight or branched C1-6 alkyl group; or a pharmaceutically acceptable salt thereof.
Patent AU-695259-B2 (AU)
Title: Hepatitis-C virus type 4, 5 and 6
Inventor: SIMMONDS PETER
IPC: C07K7/08
Filed: 1994-05-05
Granted: 1998-08-13
Abstract: The present invention relates to a polynucleic acid composition comprising or consisting of at least one polynucleic acid containing 8 or more contiguous nucleotides corresponding to a nucleotide sequence from the region spanning positions 417 to 957 of the Core/E1 region of HCV type 3; and/or the region spanning positions 4664 to 4730 of the NS3 region of HCV type 3; and/or the region spanning positions 4892 to 5292 of the NS3/4 region of HCV type 3; and/or the region spanning positions 8023 to 8235 of the NS5 region of the BR36 subgroup of HCV type 3a; and/or the coding region of HCV type 4a starting at nucleotide 379 in the core region; and/or the coding region of HCV type 4; and/or the coding region of HCV type 5, with said nucleotide numbering being with respect to the numbering of HCV nucleic acids as shown in Table 1, and with said polynucleic acids containing at least one nucleotide difference with known HCV type 1, and/or HCV type 2 genomes in the above-indicated regions, or the complement thereof.
Patent AU-751556-B2 (AU)
Title: Supplement for dialysis patients
Inventor: WALSER MACKENZIE
IPC: A61P7/00
Filed: 1998-03-13
Granted: 2002-08-22
Abstract: Use of a tablet diet supplement for administration to a dialysis patient comprising a mixture of L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-threonine, L-tryptophan, L-tyrosine and L-valine, for preventing and/or correcting hypoalbuminemia in a patient on dialysis.
Patent AU-748594-B2 (AU)
Title: A combination therapy for HIV infections
Inventor: HIRSCHMAN SHALOM Z
IPC: A61K35/20
Filed: 1998-04-15
Granted: 2002-06-06
Abstract: The present invention discloses a method of treating patients having AIDS or HIV infections by parenterally administering Product R, a peptide-nucleic acid preparation, in a combination with one or more antiviral agents useful for treating AIDS or HIV infections including HIV protease inhibitors and nucleoside analogs.
Patent AU-768299-B2 (AU)
Title: Formulation for spray-drying large porous particles
Inventor: LIPP MICHAEL M
IPC: A61K47/24
Filed: 2000-08-23
Granted: 2003-12-04
Abstract: Particles having a tap density less than about 0.4 g/cm<3> are formed by spray drying from a colloidal solution including a carboxylic acid or salt thereof, a phospholipid, a divalent salt and a solvent such as an aqueous-organic solvent. The colloidal solution can also include a therapeutic, prophylactic or diagnostic agent. Preferred carboxylic acids include at least two carboxyl groups. Preferred phospholipids include phosphatidylcholines, phosphatidylethanolamines, phosphatidylglycerols, phophAtidylserines, phosphatidylinositols and combinations thereof. The particles are suitable for pulmonary delivery.
Patent AU-647087-B2 (AU)
Title: Interproximal brush
Inventor: ZIMMERMAN WALTER
IPC: A46B3/08
Filed: 1990-12-19
Granted: 1994-03-17
Abstract: An interproximal brush comprises a handle having an end portion provided with a transverse hole communicating with a longitudinal groove for receiving the elongated stem of an interproximal brush. The handle further has a cylindrical boss formed on the lower surface thereof through which the transverse hole extends, and the brush stem is retained securely in the longitudinal groove on closure of a cap, which is pivotably attached to the end portion.
Patent AU-635125-B2 (AU)
Title: System for controlling crystal growth apparatus and melt replenishment system therefor
IPC: H01L21/208
Filed: 1991-02-21
Granted: 1993-03-11
Abstract: A control system for controlling the operation of a system for replenishing the melt in the crucible of an apparatus for growing tubular crystalline bodies of a selected material. The melt replenishment system comprises a container for storing solid particles of said selected material and a dispenser for transporting the particles from the container to the crucible. The control system controls the rate at which the dispenser transports particles from the container to the crucible based on the weight of the solid particles stored in the container, the weight of the crystalline body, and the pressure inside the crystalline body. Additionally, the control system may be adapted to control the temperature of the crucible heater of the apparatus. Compensation is provided by this invention for weight measurement errors that are created by pressure fluctuations within the tubular crystalline body.
Patent AU-742411-B2 (AU)
Title: Austenitic stainless steel having a very low nickel content
Inventor: CHESSERET LAURENT
IPC: C22C38/00
Filed: 1998-07-21
Granted: 2002-01-03
Abstract: A low nickel content austenitic stainless steel has the composition (by wt.) less than 0.1% C, 0.1-1% (exclusive) Si, 5-9% (exclusive) Mn, 0.1-2% (exclusive) Ni, 13-19% (exclusive) Cr, 1-4% (exclusive) Cu, 0.1-0.40% (exclusive) N, 5 x 10<-4>-50 x 10<-4>% (exclusive) B, less than 0.05% P and less than 0.01% S. Preferably, both the ferrite index (IF1) and the martensite stability index (IS) are less than 20, where IF1 = 0.034 x x<2> + 0.284 x x - 0.347 and IS = 0.0267 x y<2> + 0.4332 x y - 3.1459, in which x = 6.903 x Ä-6.998 + Cr% - 0.972 x (Ni% + 20.04C% + 21.31N% + 0.46Cu% + 0.08Mn%)Ü and y = 250.4 - 205.4C% - 101.4N% - 7.6Mn% - 12.1Ni% - 6.1Cr% - 13.3Cu%.
Patent AU-741753-B2 (AU)
Title: Substituted heterocyclic compounds, method for preparing and compositions containing same
Inventor: GUILLAUMET GERALD
IPC: A61P25/16
Filed: 1998-05-14
Granted: 2001-12-06
Abstract: The invention relates to compounds of formula (I):wherein:R1, R2 and R3 are as defined in the description,X is as defined in the description,Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or SO2,n is equal to from 0 to 5,A represents a NR5R6 group,and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
Patent AU-680050-B2 (AU)
Title: Transdermal therapeutic system containing octyl dodecanol ascrystallization inhibitor
Inventor: CORDES GUNTER
IPC: A61K9/70
Filed: 1994-09-30
Granted: 1997-07-17
Abstract: PCT No. PCT/EP94/03269 Sec. 371 Date Mar. 27, 1996 Sec. 102(e) Date Mar. 27, 1996 PCT Filed Sep. 30, 1994 PCT Pub. No. WO95/09618 PCT Pub. Date Apr. 13, 1995Transdermal therapeutic systems containing as active ingredients oestradiol and norethisterone acetate have added thereto octyldodecanol to reduce or avert crystal formation after storage. The use of octyldodecanol thus makes it possible to produce a storage-stable system with the active ingredients oestradiol and norethisterone acetate with a high thermodynamic activity.
Patent AU-650455-B2 (AU)
Title: Data retrieval system, display apparatus and method of recording and displaying
Inventor: POULTER GRAHAM GEORGE
IPC: H04N1/21
Filed: 1991-06-05
Granted: 1994-06-23
Abstract: An interactive data retrieval system based on a personal computer (10) is provided which comprises a database (8) and a CD-ROM (131) which is arranged to select and display visual images (18) of product literature of interest to a user such as an architect for example. The database contains details of the illustrated products and the manufacturers of the products. A modem is provided to enable the user to communicate with the manufacturers of the displayed products and to receive updating information which is stored in the database. The display of a selected image may be aborted at any time by the user, and in order to facilitate comprehension of the image as quickly as possible whilst maximising the ultimate resolution of the image, the resolution of each displayed image is gradually increased during the display process (Fig. 5). This is achieved by initially displaying the image in the form of blocks of identical pixels. The true image pixels at each position in the blocks are then substituted so as to enhance the resolution of the image. An arrangement for displaying an image which has been scanned at a spatial resolution which is different from the nominal spatial resolution of the monitor is also described (Fig. 8). <IMAGE>
Patent AU-639807-B2 (AU)
Title: Novel bis(4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents
IPC: A61P5/38
Filed: 1991-07-03
Granted: 1993-08-05
Abstract: The present invention relates to certain bis[4-(2,6-di-alkyl)phenol]silane derivatives which are useful as inhibitors of LDL lipid peroxidation and as antiatherosclerotic agents.